General

Reverse Giving Tuesday: A video for you!
By: Charles Eaton
Nov 29, 2022

It’s Giving Tuesday, a traditional fundraising push for nonprofits. The Dupuytren Research Group is flipping this to Reverse Giving Tuesday with a gift for you: a new video seminar reviewing Dupuytren disease, its challenges, and the strategy behind our research for a cure. https://www.youtube.com/watch?v=LkOronhIgQU Of course, your financial support is critical https://CureDup.com, but this time we’re […]

Read more ›
The ‘most common crippling hand condition’ you’ve never heard of
On: Nov 20, 2022
By: Charles Eaton

The Washington Post just published an article about Dupuytren disease mentioning the Dupuytren Research Group and two of its directors, Gary Pess MD and Charles Eaton MD. https://www.washingtonpost.com/wellness/2022/11/20/dupuytrens-crippling-hand-disease-treatments/ Progress toward a Dupuytren cure begins with raising awareness about Dupuytren prevalence and problems. Please share this widely!  

Read more ›
Three Exciting Dupuytren Updates and a Public Seminar
On: Oct 30, 2022
By: Charles Eaton

I want to share three exciting Dupuytren updates with you this Halloween. The first update is the growing use of artificial intelligence (AI) in medical research. The term “Artificial Intelligence” is a little misleading. Today, AI is about computerized pattern-matching rather than thinking and consciousness, but it’s still amazing. The pumpkin pictures above are all […]

Read more ›
Disease Modifying AntiDupuytren Drugs
On: Sep 7, 2022
By: Charles Eaton

The path to a Dupuytren cure is connected to the story of drugs for rheumatoid arthritis. The evolution of rheumatoid drug treatment dates back centuries, based on guesswork and trial and error. During this time, hundreds of rheumatoid “cures” were recommended – herbs, diets, bedrest, baths, special clothing, radioactive exposure, special jewelry, injections of arsenic […]

Read more ›
August is National Make a Will month
On: Aug 25, 2022
By: Charles Eaton

Here at the Dupuytren Research Group, we’re planning for the future. Dupuytren spans generations. Our work centers on families. That’s why it’s the perfect time to be reminded that August is National Make a Will Month. Wills are essential regardless of wealth. They are about you – protecting your loved ones, avoiding family feuds, and preventing the government’s […]

Read more ›
NHS Dupuytren Information
On: Jul 22, 2022
By: Charles Eaton

Dupuytren is complicated. Much of it is a mystery. Because it’s not understood, describing it makes me feel like a character in the parable of the blind men and the elephant. Seeing the Dupuytren brochure recently released by England’s National Health Service is a pleasant surprise. It summarizes information from publications, answers common questions, and […]

Read more ›
Happy International Women’s Day!
On: Mar 8, 2022
By: Charles Eaton

Happy International Women’s Day The story that God created man before creating woman is an example of working on the rough draft before the final masterpiece. A traditional Dupuytren narrative is that Dupuytren is primarily a painless nuisance problem of bent fingers in old men. This perception does a disservice to many. Not only is […]

Read more ›
One last 2021 request
On: Dec 28, 2021
By: Charles Eaton

The Dupuytren Research Group works all year to balance our need for funding with your need to be free from fundraising solicitations. We’re working hard on research for a Dupuytren cure. We work to raise awareness about Dupuytren disease and the need for Dupuytren research funding. We provide educational resources for all and one-on-one consultation […]

Read more ›
Happy Holidays from DRG
On: Dec 22, 2021
By: Charles Eaton

When we all lend a hand helping the community we improve everyone’s quality of life. Best wishes in this holiday season from the Dupuytren Research Group

Read more ›
Don’t forget Dupuytren on Giving Tuesday!
On: Nov 29, 2021
By: Charles Eaton

The Dupuytren Research Group’s work is supported entirely by your charitable gifts. Thanks to you, our blood test pilot study has completed blood sample collection, and analysis is underway. This is the first step toward a large research study to develop a Dupuytren blood test. We’ve made it this far because of the Dupuytren community’s […]

Read more ›